U.S. senator reveals results of opioid inquiry into Insys
September 06, 2017 at 17:48 PM EDT
BOSTON, Sept 6 (Reuters) - Insys Therapeutics Inc sought to manipulate the process to gain insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report related to the national opioid addiction crisis released on Wednesday.